S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
SWOG Cancer Research Network
University of California, San Francisco
University of Washington
Providence Health & Services
National Cancer Institute (NCI)
City of Hope Medical Center
Washington University School of Medicine
Pennington Biomedical Research Center
Trinity Health Michigan
Elicio Therapeutics
Institut Bergonié
National Cancer Institute (NCI)
SafeHeal Inc
Academic and Community Cancer Research United
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Asan Medical Center
Stanford University
University of Oxford
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Stanford University
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Asan Medical Center
Canadian Cancer Trials Group
Hutchmed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NantBioScience, Inc.
National Cancer Institute (NCI)
Academic and Community Cancer Research United
University of Pittsburgh
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of North Carolina, Chapel Hill
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eisai Inc.
Trinity Health Michigan
Advaxis, Inc.
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Amgen
Amgen